Biogen (BIIB) Revenue — Quarter Ended Jun 30, 2025
Revenue increased in the current quarter compared to both the prior quarter and the same quarter last year. The sequential and year-over-year gains reflect a continuation of the upward trend observed over recent periods.
Key takeaway
Quarter ended Jun 30, 2025 · FY2025 Q2
Revenue increased in the current quarter compared to both the prior quarter and the same quarter last year. The sequential and year-over-year gains reflect a continuation of the upward trend observed over recent periods.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$2.6B
Revenue reported for this quarter.
Quarter-over-quarter
+8.8%
Change from the immediately preceding quarter.
Year-over-year
+7.3%
Change from the comparable year-ago quarter.
Trailing four quarters
$10B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Sep 30, 2024 | $2.5B | -2.5% |
| Dec 31, 2024 | $2.5B | +2.9% |
| Mar 31, 2025 | $2.4B | +6.1% |
| Jun 30, 2025 | $2.6B | +7.3% |
Revenue performance
Reported revenue rose from the immediately preceding quarter, marking a positive sequential performance. The year-over-year comparison also showed an increase, indicating sustained growth relative to the same period a year earlier.
Quarterly comparison
Compared to the prior quarter, revenue improved, continuing the upward trajectory seen in recent quarters. Versus the same quarter one year ago, revenue was also higher, extending the positive year-over-year trend.
What to watch
Monitor whether the sequential revenue growth rate can be sustained in the coming quarters.